In late 1996 Stephen Henry returned to New Zealand and founded Kiwi Ingenuity Limited. His aim was practical: better quality-control products for blood banks, built from his research on blood-group glycolipids.
In 1999 the technology was named KODE, originally short for Kiwi, Ortho, Designer, Erythrocytes. In April 2006 the company took the name of its technology and became Kode Biotech Limited.
From the first synthetic Function-Spacer-Lipid construct in 2003, Kode Biotech has built a platform that attaches almost any small molecule to almost any surface, and has sold products based on it since 2005.